{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:32:21Z","timestamp":1786365141950,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Wilson\u2019s disease (WD) is a rare autosomal recessive disorder caused by mutations in the ATP7B gene, leading to copper metabolism dysfunction. The clinical and genetic manifestations of WD vary across populations. This study aimed to characterize the clinical features and genetic mutations in WD patients from southwestern China and to explore genotype-phenotype correlations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 120 WD patients from southwestern China were included. Clinical data were collected through face-to-face interviews and medical record reviews. ATP7B mutations were identified through whole-genome resequencing. Genotype-phenotype correlations were analyzed in patients with pathogenic mutations on both alleles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 120 WD patients, the median age at onset was 17 years (range 3 to 49 years), with neurological symptoms being the most common initial presentation (61.7%). At the time of enrollment, the median disease duration was 10 years, with persistent neurological symptoms commonly observed, and 62.5% of patients had progressed to cirrhosis. Sex and age differences in clinical characteristics were also observed. In the analysis of ATP7B gene mutations, a total of 47 distinct pathogenic mutations were identified, including 32 missense, 6 nonsense, 6 frameshift, and 3 splicing mutations. The most prevalent mutations were c.2333G\u2009&gt;\u2009T (p.R778L) and c.2975\u00a0C\u2009&gt;\u2009T (p.P992L). Notably, one novel pathogenic frameshift mutation, c.386delA (p.K129Rfs*24), and another novel variant of uncertain significance, c.1987\u00a0C\u2009&gt;\u2009A (p.P663T), were identified. Among the 117 unrelated patients, 98 (83.8%) had pathogenic mutations on both alleles, with 62 different mutation combinations observed. Genotype-phenotype analysis showed that p.R778L, p.P992L, and loss-of-function (LOF) mutations were not significantly associated with the initial clinical subtype, whereas p.R778L was associated with a later age at onset and LOF mutations with an earlier age at onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provided some valuable insights into the clinical and genetic characteristics of WD in southwestern China, enhanced the understanding of genotype-phenotype correlations, and emphasized the importance of early diagnosis and personalized management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04426-y","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:04:07Z","timestamp":1780463047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and genetic features of patients with Wilson\u2019s disease in southwestern China"],"prefix":"10.1186","volume":"21","author":[{"given":"Lu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieru","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dailan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"9559","key":"4426_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","volume":"369","author":"A Ala","year":"2007","unstructured":"Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson\u2019s disease. Lancet. 2007;369(9559):397\u2013408.","journal-title":"Lancet"},{"issue":"2","key":"4426_CR2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.30911","volume":"71","author":"TD Sandahl","year":"2020","unstructured":"Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P. The Prevalence of Wilson\u2019s Disease: An Update. Hepatology. 2020;71(2):722\u201332.","journal-title":"Hepatology"},{"issue":"5","key":"4426_CR3","first-page":"1155","volume":"21","author":"J Gao","year":"2019","unstructured":"Gao J, Brackley S, Mann JP. The global prevalence of Wilson disease from next-generation sequencing data. Genet Sci. 2019;21(5):1155\u201363.","journal-title":"Genet Sci"},{"issue":"1","key":"4426_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","volume":"14","author":"O Bandmann","year":"2015","unstructured":"Bandmann O, Weiss KH, Kaler SG. Wilson\u2019s disease and other neurological copper disorders. Lancet Neurol. 2015;14(1):103\u201313.","journal-title":"Lancet Neurol"},{"issue":"2","key":"4426_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/MPG.0000000000003322","volume":"74","author":"P Lorente-Arencibia","year":"2022","unstructured":"Lorente-Arencibia P, Garcia-Villarreal L, Gonzalez-Montelongo R, Rubio-Rodriguez LA, Flores C, Garay-Sanchez P, et al. Wilson Disease Prevalence: Discrepancy Between Clinical Records, Registries and Mutation Carrier Frequency. J Pediatr Gastroenterol Nutr. 2022;74(2):192\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"4426_CR6","doi-asserted-by":"publisher","first-page":"14041","DOI":"10.1038\/s41598-020-70976-1","volume":"10","author":"EJ Choe","year":"2020","unstructured":"Choe EJ, Choi JW, Kang M, Lee YK, Jeon HH, Park BK, et al. A population-based epidemiology of Wilson\u2019s disease in South Korea between 2010 and 2016. Sci Rep. 2020;10(1):14041.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"4426_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jns.2011.08.028","volume":"312","author":"T Litwin","year":"2012","unstructured":"Litwin T, Gromadzka G, Cz\u0142onkowska A. Gender differences in Wilson\u2019s disease. J Neurol Sci. 2012;312(1\u20132):31\u20135.","journal-title":"J Neurol Sci"},{"issue":"11","key":"4426_CR8","first-page":"e11509","volume":"12","author":"JF Ortiz","year":"2020","unstructured":"Ortiz JF, Morillo Cox \u00c1, Tambo W, Eskander N, Wirth M, Valdez M, et al. Neurological Manifestations of Wilson\u2019s Disease: Pathophysiology and Localization of Each Component. Cureus. 2020;12(11):e11509.","journal-title":"Cureus"},{"issue":"9","key":"4426_CR9","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1007\/s10072-020-05013-0","volume":"42","author":"B Samanci","year":"2021","unstructured":"Samanci B, Sahin E, Bilgic B, Tufekcioglu Z, Gurvit H, Emre M, et al. Neurological features and outcomes of Wilson\u2019s disease: a single-center experience. Neurol Sci. 2021;42(9):3829\u201334.","journal-title":"Neurol Sci"},{"key":"4426_CR10","doi-asserted-by":"publisher","first-page":"1176946","DOI":"10.3389\/fneur.2023.1176946","volume":"14","author":"L Cai","year":"2023","unstructured":"Cai L, Huang X, Ye Y, Yang D, Xie L, Fu D, et al. Role of gender and age in features of Wilson\u2019s disease. Front Neurol. 2023;14:1176946.","journal-title":"Front Neurol"},{"issue":"1","key":"4426_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.genhosppsych.2013.08.007","volume":"36","author":"PC Zimbrean","year":"2014","unstructured":"Zimbrean PC, Schilsky ML. Psychiatric aspects of Wilson disease: a review. Gen Hosp Psychiatry. 2014;36(1):53\u201362.","journal-title":"Gen Hosp Psychiatry"},{"key":"4426_CR12","doi-asserted-by":"crossref","unstructured":"Hou H, Chen D, Liu J, Feng L, Zhang J, Liang X, et al. Clinical and genetic analysis in neurological Wilson\u2019s disease patients with neurological worsening following chelator therapy. Front Genet. 2022;13.","DOI":"10.3389\/fgene.2022.875694"},{"issue":"7","key":"4426_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.medcli.2024.02.004","volume":"163","author":"S Jin","year":"2024","unstructured":"Jin S, Sun Z, Fang X, Yang W. Characterization of renal damage in Wilson\u2019s disease-Detailed analysis of 20 Chinese cases. Med Clin (Barc). 2024;163(7):360\u20136.","journal-title":"Med Clin (Barc)"},{"issue":"Suppl 2","key":"4426_CR14","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.21037\/atm.2019.04.27","volume":"7","author":"S Shribman","year":"2019","unstructured":"Shribman S, Warner TT, Dooley JS. Clinical presentations of Wilson disease. Ann Transl Med. 2019;7(Suppl 2):S60.","journal-title":"Ann Transl Med"},{"issue":"4","key":"4426_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ng1293-338","volume":"5","author":"K Petrukhin","year":"1993","unstructured":"Petrukhin K, Fischer SG, Pirastu M, Tanzi RE, Chernov I, Devoto M, et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet. 1993;5(4):338\u201343.","journal-title":"Nat Genet"},{"issue":"4","key":"4426_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/ng1293-327","volume":"5","author":"PC Bull","year":"1993","unstructured":"Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993;5(4):327\u201337.","journal-title":"Nat Genet"},{"issue":"1","key":"4426_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1006\/bbrc.1993.2471","volume":"197","author":"Y Yamaguchi","year":"1993","unstructured":"Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun. 1993;197(1):271\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"4426_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","volume":"56","author":"European Association for the Study of the L","year":"2012","unstructured":"European Association for the Study of the L. EASL Clinical Practice Guidelines: Wilson\u2019s disease. J Hepatol. 2012;56(3):671\u201385.","journal-title":"J Hepatol"},{"key":"4426_CR19","doi-asserted-by":"crossref","unstructured":"Penning LC, Berenguer M, Czlonkowska A, Double KL, Dusek P, Espin\u00f3s C, et al. A century of progress on Wilson disease and the enduring challenges of genetics, diagnosis, and treatment. 2023;11(2):420.","DOI":"10.3390\/biomedicines11020420"},{"issue":"2","key":"4426_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00439-006-0202-5","volume":"120","author":"P Ferenci","year":"2006","unstructured":"Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet. 2006;120(2):151\u20139.","journal-title":"Hum Genet"},{"key":"4426_CR21","doi-asserted-by":"crossref","unstructured":"Zhang S, Yang W, Li X, Pei P, Dong T, Yang Y, et al. Clinical and genetic characterization of a large cohort of patients with Wilson\u2019s disease in China. Translational Neurodegeneration. 2022;11(1).","DOI":"10.1186\/s40035-022-00287-0"},{"issue":"1","key":"4426_CR22","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s12887-024-05045-x","volume":"24","author":"T Zhang","year":"2024","unstructured":"Zhang T, Song W, Mao Z. Phenotypic and genetic characterization of children with Wilson Disease from Northeast China. BMC Pediatr. 2024;24(1):576.","journal-title":"BMC Pediatr"},{"issue":"1","key":"4426_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12876-021-01911-5","volume":"21","author":"M Li","year":"2021","unstructured":"Li M, Ma J, Wang W, Yang X, Luo K. Mutation analysis of the ATP7B gene and genotype-phenotype correlation in Chinese patients with Wilson disease. BMC Gastroenterol. 2021;21(1):339.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"4426_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/cge.12951","volume":"92","author":"N Cheng","year":"2017","unstructured":"Cheng N, Wang H, Wu W, Yang R, Liu L, Han Y, et al. Spectrum of ATP7B mutations and genotype-phenotype correlation in large-scale Chinese patients with Wilson Disease. Clin Genet. 2017;92(1):69\u201379.","journal-title":"Clin Genet"},{"issue":"8","key":"4426_CR25","first-page":"566","volume":"41","author":"Chinese Society of Parkinson\u2019s Disease and Movement Disorders CSoN","year":"2008","unstructured":"Chinese Society of Parkinson\u2019s Disease and Movement Disorders CSoN. Guidelines for diagnosis and treatment of hepatolenticular degeneration. Chin J Neurol. 2008;41(8):566\u20139.","journal-title":"Chin J Neurol"},{"issue":"3","key":"4426_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1034\/j.1600-0676.2003.00824.x","volume":"23","author":"P Ferenci","year":"2003","unstructured":"Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver international: official J Int Association Study Liver. 2003;23(3):139\u201342.","journal-title":"Liver international: official J Int Association Study Liver"},{"issue":"1","key":"4426_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40035-022-00287-0","volume":"11","author":"S Zhang","year":"2022","unstructured":"Zhang S, Yang W, Li X, Pei P, Dong T, Yang Y, et al. Clinical and genetic characterization of a large cohort of patients with Wilson\u2019s disease in China. Translational Neurodegeneration. 2022;11(1):13.","journal-title":"Translational Neurodegeneration"},{"issue":"5","key":"4426_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"6","key":"4426_CR29","doi-asserted-by":"publisher","first-page":"101402","DOI":"10.1016\/j.gim.2025.101402","volume":"27","author":"T Bergquist","year":"2025","unstructured":"Bergquist T, Stenton SL, Nadeau EAW, Byrne AB, Greenblatt MS, Harrison SM, et al. Calibration of additional computational tools expands ClinGen recommendation options for variant classification with PP3\/BP4 criteria. Genet Med. 2025;27(6):101402.","journal-title":"Genet Med"},{"issue":"12","key":"4426_CR30","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","volume":"109","author":"V Pejaver","year":"2022","unstructured":"Pejaver V, Byrne AB, Feng BJ, Pagel KA, Mooney SD, Karchin R, et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria. Am J Hum Genet. 2022;109(12):2163\u201377.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"4426_CR31","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","volume":"39","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun AN, Pesaran T, DiStefano MT, Oza A, Rehm HL, Biesecker LG, et al. Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion. Hum Mutat. 2018;39(11):1517\u201324.","journal-title":"Hum Mutat"},{"issue":"4","key":"4426_CR32","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/hep.30280","volume":"69","author":"P Ferenci","year":"2019","unstructured":"Ferenci P, Stremmel W, Cz\u0142onkowska A, Szalay F, Viveiros A, St\u00e4ttermayer AF, et al. Age and sex but not ATP7B genotype effectively influence the clinical phenotype of Wilson disease. Hepatology. 2019;69(4):1464\u201376.","journal-title":"Hepatology"},{"key":"4426_CR33","doi-asserted-by":"crossref","unstructured":"Sobesky R, Darce M, Agostini H, Fernandez I, Usardi A, Adam R, et al. Clinical presentation and outcome of Wilson\u2019s disease patients in a monocentric cohort of liver reference center. 2018;68.","DOI":"10.1016\/S0168-8278(18)31516-2"},{"issue":"12","key":"4426_CR34","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1080\/14737175.2023.2268841","volume":"23","author":"T Litwin","year":"2023","unstructured":"Litwin T, Dusek P, Antos A, Cz\u0142onkowska A, Bembenek J. Tackling the neurological manifestations in Wilson\u2019s disease \u2013 currently available treatment options. Expert Rev Neurother. 2023;23(12):1249\u201359.","journal-title":"Expert Rev Neurother"},{"key":"4426_CR35","doi-asserted-by":"publisher","first-page":"101768","DOI":"10.1016\/j.bpg.2021.101768","volume":"56\u201357","author":"P Socha","year":"2022","unstructured":"Socha P, Czlonkowska A, Janczyk W, Litwin T. Wilson\u2019s disease- management and long term outcomes. Best Pract Res Clin Gastroenterol. 2022;56\u201357:101768.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"4426_CR36","doi-asserted-by":"crossref","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. 2019;70(4):1457\u201369.","DOI":"10.1002\/hep.30626"},{"key":"4426_CR37","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.csbj.2019.07.021","volume":"17","author":"NJ Hunt","year":"2019","unstructured":"Hunt NJ, Kang SWS, Lockwood GP, Le Couteur DG, Cogger VC. Hallmarks of Aging in the Liver. Comput Struct Biotechnol J. 2019;17:1151\u201361.","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"4426_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/cge.12951","volume":"92","author":"N Cheng","year":"2017","unstructured":"Cheng N, Wang H, Wu W, Yang R, Liu L, Han Y, et al. Spectrum of mutations and genotype\u2013phenotype correlation in large-scale Chinese patients with Wilson Disease. Clin Genet. 2017;92(1):69\u201379.","journal-title":"Clin Genet"},{"issue":"8","key":"4426_CR39","doi-asserted-by":"publisher","first-page":"e1741","DOI":"10.1002\/mgg3.1741","volume":"9","author":"L Qiao","year":"2021","unstructured":"Qiao L, Ge J, Li C, Liu Y, Hu C, Hu S, et al. Pathogenic gene variation spectrum and carrier screening for Wilson\u2019s disease in Qingdao area. Mol Genet Genom Med. 2021;9(8):e1741.","journal-title":"Mol Genet Genom Med"},{"key":"4426_CR40","doi-asserted-by":"publisher","first-page":"871877","DOI":"10.3389\/fcell.2022.871877","volume":"10","author":"S Dev","year":"2022","unstructured":"Dev S, Kruse RL, Hamilton JP, Lutsenko S. Wilson Disease: Update on Pathophysiology and Treatment. Front Cell Dev Biol. 2022;10:871877.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"4426_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2353\/ajpath.2006.050312","volume":"168","author":"D Huster","year":"2006","unstructured":"Huster D, Finegold MJ, Morgan CT, Burkhead JL, Nixon R, Vanderwerf SM, et al. Consequences of copper accumulation in the livers of the Atp7b-\/- (Wilson disease gene) knockout mice. Am J Pathol. 2006;168(2):423\u201334.","journal-title":"Am J Pathol"},{"issue":"1","key":"4426_CR42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41598-017-18951-1","volume":"8","author":"CH Yu","year":"2018","unstructured":"Yu CH, Lee W, Nokhrin S, Dmitriev OY. The Structure of Metal Binding Domain 1 of the Copper Transporter ATP7B Reveals Mechanism of a Singular Wilson Disease Mutation. Sci Rep. 2018;8(1):581.","journal-title":"Sci Rep"},{"issue":"9","key":"4426_CR43","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1039\/c9mt00147f","volume":"11","author":"KP Shanmugavel","year":"2019","unstructured":"Shanmugavel KP, Wittung-Stafshede P. Copper relay path through the N-terminus of Wilson disease protein, ATP7B\u2020. Metallomics. 2019;11(9):1472\u201380.","journal-title":"Metallomics"},{"key":"4426_CR44","doi-asserted-by":"crossref","unstructured":"Braiterman LT, Murthy A, Jayakanthan S, Nyasae L, Tzeng E, Gromadzka G, et al. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B. Proceedings of the National Academy of Sciences. 2014;111(14):E1364-E73.","DOI":"10.1073\/pnas.1314161111"},{"issue":"4","key":"4426_CR45","doi-asserted-by":"publisher","first-page":"100114","DOI":"10.1016\/j.jhepr.2020.100114","volume":"2","author":"C Espin\u00f3s","year":"2020","unstructured":"Espin\u00f3s C, Ferenci P. Are the new genetic tools for diagnosis of Wilson disease helpful in clinical practice? JHEP Rep. 2020;2(4):100114.","journal-title":"JHEP Rep"},{"issue":"10","key":"4426_CR46","doi-asserted-by":"publisher","first-page":"e1428","DOI":"10.1002\/mgg3.1428","volume":"8","author":"F Woimant","year":"2020","unstructured":"Woimant F, Poujois A, Bloch A, Jordi T, Laplanche JL, Morel H, et al. A novel deep intronic variant in ATP7B in five unrelated families affected by Wilson disease. Mol Genet Genomic Med. 2020;8(10):e1428.","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"4426_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2350-12-6","volume":"12","author":"X-H Li","year":"2011","unstructured":"Li X-H, Lu Y, Ling Y, Fu Q-C, Xu J, Zang G-Q, et al. Clinical and molecular characterization of Wilson\u2019s disease in China: identification of 14 novel mutations. BMC Med Genet. 2011;12(1):6.","journal-title":"BMC Med Genet"},{"issue":"1","key":"4426_CR48","doi-asserted-by":"publisher","first-page":"13487","DOI":"10.1038\/s41598-020-70366-7","volume":"10","author":"S Roy","year":"2020","unstructured":"Roy S, McCann CJ, Ralle M, Ray K, Ray J, Lutsenko S, et al. Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties. Sci Rep. 2020;10(1):13487.","journal-title":"Sci Rep"},{"issue":"1","key":"4426_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40035-022-00287-0","volume":"11","author":"S Zhang","year":"2022","unstructured":"Zhang S, Yang W, Li X, Pei P, Dong T, Yang Y, et al. Clinical and genetic characterization of a large cohort of patients with Wilson\u2019s disease in China. Transl Neurodegener. 2022;11(1):13.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"4426_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-230X-10-8","volume":"10","author":"U Merle","year":"2010","unstructured":"Merle U, Weiss KH, Eisenbach C, Tuma S, Ferenci P, Stremmel W. Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease. BMC Gastroenterol. 2010;10(1):8.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"4426_CR51","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1399-0004.2005.00528.x","volume":"68","author":"G Gromadzka","year":"2005","unstructured":"Gromadzka G, Schmidt HHJ, Genschel J, Bochow B, Rodo M, Tarnacka B, et al. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson\u2019s disease. Clin Genet. 2005;68(6):524\u201332.","journal-title":"Clin Genet"},{"issue":"1","key":"4426_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/liv.13967","volume":"39","author":"A Kluska","year":"2019","unstructured":"Kluska A, Kulecka M, Litwin T, Dziezyc K, Balabas A, Piatkowska M, et al. Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson\u2019s disease phenotype. Liver Int. 2019;39(1):177\u201386.","journal-title":"Liver Int"},{"key":"4426_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/B978-0-444-63625-6.00004-5","volume":"142","author":"V Medici","year":"2017","unstructured":"Medici V, Weiss KH. Genetic and environmental modifiers of Wilson disease. Handb Clin Neurol. 2017;142:35\u201341.","journal-title":"Handb Clin Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04426-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04426-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04426-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:04:15Z","timestamp":1786363455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04426-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4426"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04426-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed with the approval of the Ethics Committee of West China School of Public Health and West China Fourth Hospital (Gwll2023126) and adhered to the Declaration of Helsinki. All the written informed consent was obtained from participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"274"}}